Main Category: Neurology / Neuroscience Also Included In: Clinical Trials / Drug Trials ; Regulatory Affairs / Drug Approvals Article Date: 17 Aug 2009 - 5:00 PDT Australian regenerative medicine company, Mesoblast Limited , announced that it has received clearance from the United States Food and Drug Administration for a Phase 2 clinical trial of ...
More...
(From Topix Neurology)